MBC BioLabs is excited to announce a strategic partnership with Fujifilm Open Innovation Hub to support biotech collaboration and innovation in our startup ecosystem.
AbbVie, a leading global biopharmaceutical company, has purchased an exclusive right to acquire Mitokinin following completion of IND enabling studies on Mitokinin's lead PINK1 compound.
The investment was led by professional and angel investor groups consisting of current and former pharmaceutical executives and physicians.
BigHat Biosciences, a novel protein therapeutics company and developer of an AI-guided antibody design platform, announced it has raised $19 million in an oversubscribed Series A funding round.
The partnership will provide Charles River clients with access to Cypre’s proprietary 3D tumor model platform, Falcon-X™, which will expand Charles River’s 3D in vitro testing services to further optimize immuno-oncological approaches for its clients.
MBC BioLabs alum, Trevor Martin, is named Executive of the Year 2020 by San Francisco Business Times